News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) CEO's 2010 Remuneration Cut Due to Missed Profit Targets



3/3/2011 8:25:06 AM

LONDON (Dow Jones)--GlaxoSmithKline PLC's (GSK) Chief Executive Andrew Witty had his remuneration cut by 24% last year because the U.K.'s biggest drug maker missed its profit targets.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES